Future Price to Earnings: newgenivf.com (NIVF)
NewGenIvf Group Limited is implementing advanced genetic infertility treatments, although the robotization of microinjections remains in the testing phase. The company's forward P/E ratio, provided by the GURU.Markets website, reconciles these aspects, with the 0.00 mark indicating the level of market expectations. However, intense competition in Asia and rising costs continue to pressure free cash flow.
Summary analytical data breakdowns for NewGenIvf Corp (NIVF)
- stock quotes and analyst forecast:
- company stock exchange capitalization indicators:
- balance sheet equity data:
- business debt structure and liquidity details:
Total Debt to Capital NewGenIvf Group Limited|NIVF - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio NewGenIvf Group Limited|NIVF - Company Total Debt|Debts to Book Capitalization NewGenIvf Group Limited|NIVF - Long-Term Indebtedness|Company Short-Term Debts NewGenIvf|Quick Liquidity newgenivf.com
- financial results and valuation multiples details:
NIVF - Company Profit|Projected Future Earnings NewGenIvf Group Limited|NIVF - Business Payback Period|Projected Price to Earnings NewGenIvf Group Ltd|NIVF - Price/Earnings to Growth Ratio|EV/EBITDA Multiple NewGenIvf Group Limited|NIVF - Profit before deduction of interest, taxes, depreciation and amortization|Net earnings per share for the last 12 months NewGenIvf|NIVF - Earnings per share for the trailing year|Quarterly EPS earnings growth newgenivf.com|NIVF - Net earnings per share change in current year|Net earnings per share growth forecast for next year NewGenIvf Group Limited
Fundamental company analysis:NewGenIvf
The investment attractiveness of NewGenIvf Group Limited (NIVF) depends on the distribution efficiency of materials for reproduction clinics in Asia, which directly impacts projected profits. By analyzing the company's forward P/E ratio, an investor assesses the current share price relative to expected annual earnings, determining the asset's degree of overbought status and the risk of a correction upon reaching the upper bounds of the multiplier's normal range.
Competitor analysis
Forward P/E Multiple HCA|THC - Projected Price to Earnings Ratio|Future Price to Earnings Fresenius Medical Care Corp FMS|SOLV: Price to Future Earnings Ratio|EHC: Projected Price to Earnings|Universal Health Services - Market Cap to Future Earnings Ratio|DaVita (DVA) - Future Price to Earnings|Price to Future Earnings Ratio RDNT|OPCH (Option Care Health Inc) - Forward P/E Multiple|Projected Price to Earnings Ratio Surgery Partners Group SGRY|Projected Price to Earnings PINC (Premier, Inc.)|Projected Price to Earnings nationalvision.com EYE|Forward P/E Multiple PGNY (Progyny)|Forward Price to Earnings Multiple Ardent Health|Select Medical Corp - Forward P/E Multiple|Projected Price to Earnings Ratio Astrana Corp|mednax.com (MD) - Future Price to Earnings|Price to Future Earnings Ratio USPH|PNTG (The Pennant Group) - Forward P/E Multiple|Organogenesis Holdings Inc. (ORGO) - Market Cap to Projected Earnings|Projected Price to Earnings NUTX (Nutex Health Corp)|Future Price to Earnings AUNA (Auna Corp)|Forward P/E Multiple SBC (SBC Medical Group Holdings Inc)|EOLS (evolus.com) - Price to Expected Earnings Ratio|CYH: Projected Price to Earnings|Future Price to Earnings Multiple SKIN (The Beauty Health)|MDWD: Forward P/E Multiple|Forward Price to Earnings Multiple Biote Corporation BTMD|Future Price to Earnings The Joint Corp.|DCGO: Future Price to Earnings Multiple|Future Price to Earnings P3 Health Partners Inc. (PIII)|GANX - Projected Price to Earnings Ratio|EUDA Health - Projected Price to Earnings|Forward P/E Multiple Basel Medical BMGL|CLGN - Future Price to Earnings|Price to Expected Earnings Ratio CUPR|CCM (Concord Medical) - Projected Price to Earnings|American Shared Hospital Services Inc - Future Price to Earnings Multiple|Future Price to Earnings MEDIROM Healthcare Group Inc|Future Price to Earnings ALBT|Forward P/E Multiple DHAI|Market Cap to Projected Earnings carmellcosmetics.com|Future Price to Earnings ATI Physical Therapy, Inc. ATIP|CMAX - Projected Price to Earnings|Kindly MD Corp - Forward P/E Multiple|Market Cap to Projected Earnings ModivCare Corp MODV|NVOS (Novo Integrated Sciences) - Projected Price to Earnings|SSY: Market Cap to Future Earnings Ratio|BACK (IMAC Holdings) - Forward P/E Multiple
